H. Lundbeck A/S
🇩🇰Denmark
- Country
- 🇩🇰Denmark
- Ownership
- Public, Subsidiary
- Established
- 2000-01-01
- Employees
- 5.6K
- Market Cap
- -
- Website
- http://www.lundbeck.com
Randomised Placebo-controlled Duloxetine-referenced Efficacy and Safety Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder
Phase 3
Completed
- Conditions
- Major Depressive Disorder
- Interventions
- First Posted Date
- 2008-03-13
- Last Posted Date
- 2014-02-11
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 766
- Registration Number
- NCT00635219
Efficacy and Safety of Lu AA34893 in Patients With Bipolar Depression
Phase 2
Terminated
- Conditions
- Depression in Patients With Bipolar Disorder
- Interventions
- First Posted Date
- 2008-02-22
- Last Posted Date
- 2010-09-27
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 166
- Registration Number
- NCT00622245
- Locations
- 🇧🇪
BE004, Bruxelles, Belgium
🇵🇱PL002, Gdansk, Poland
🇦🇺AU001, Brisbane, Australia
Dose-finding Study With Lu AA24530 in Major Depressive Disorder
Phase 2
Completed
- Conditions
- Major Depressive Disorder
- Interventions
- First Posted Date
- 2008-01-24
- Last Posted Date
- 2016-11-08
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 652
- Registration Number
- NCT00599911
- Locations
- 🇺🇦
UA001, Odessa, Ukraine
🇺🇦UA005, Kharkov, Ukraine
🇧🇪BE003, Diest, Belgium
Efficacy of Vortioxetine (Lu AA21004) in the Prevention of Relapse of Major Depressive Episodes
Phase 3
Completed
- Conditions
- Major Depressive Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-01-17
- Last Posted Date
- 2014-03-31
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 639
- Registration Number
- NCT00596817
Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)
Phase 3
Terminated
- Conditions
- Primary Insomnia
- First Posted Date
- 2007-01-11
- Last Posted Date
- 2015-01-14
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 138
- Registration Number
- NCT00420810
Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED)
Phase 2
Terminated
- Conditions
- Primary Insomnia
- First Posted Date
- 2005-12-16
- Last Posted Date
- 2015-01-14
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 50
- Registration Number
- NCT00266357
MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED)
Phase 2
Completed
- Conditions
- Primary Insomnia
- First Posted Date
- 2005-12-16
- Last Posted Date
- 2015-01-14
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 520
- Registration Number
- NCT00266344
A Study of Gaboxadol in Primary Insomnia
Phase 3
Completed
- Conditions
- Primary Insomnia
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2007-03-30
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 505
- Registration Number
- NCT00209924
- Locations
- 🇸🇪
Non-US study, principal location:, Göteborg, Sweden
A Study of Gaboxadol in Primary Insomnia
Phase 3
Completed
- Conditions
- Primary Insomnia
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2007-03-30
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 600
- Registration Number
- NCT00209963
A Study of Gaboxadol in Primary Insomnia
Phase 3
Completed
- Conditions
- Primary Insomnia
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2007-03-30
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 320
- Registration Number
- NCT00209846
- Locations
- 🇸🇪
Non-US study, principal location:, Göteborg, Sweden
© Copyright 2025. All Rights Reserved by MedPath